-
ARQT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Arcutis Biotherapeutics (ARQT)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 135.47 mm | 135.47 mm | 135.47 mm | 135.47 mm | 135.47 mm | 135.47 mm |
Cash burn (monthly) | (no burn) | (no burn) | 13.02 mm | 15.16 mm | 11.56 mm | 13.97 mm |
Cash used (since last report) | n/a | n/a | 52.38 mm | 60.98 mm | 46.51 mm | 56.20 mm |
Cash remaining | n/a | n/a | 83.09 mm | 74.48 mm | 88.96 mm | 79.27 mm |
Runway (months of cash) | n/a | n/a | 6.4 | 4.9 | 7.7 | 5.7 |
13F holders | Current |
---|---|
Total holders | 189 |
Opened positions | 33 |
Closed positions | 30 |
Increased positions | 71 |
Reduced positions | 48 |
13F shares | Current |
---|---|
Total value | 1.16 tn |
Total shares | 139.71 mm |
Total puts | 82.00 k |
Total calls | 737.70 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Jennison Associates | 11.66 mm | $108.47 bn |
Rubric Capital Management | 10.97 mm | $101.99 bn |
Suvretta Capital Management | 10.72 mm | $99.71 bn |
BlackRock | 9.03 mm | $83.97 bn |
Frazier Life Sciences VIII | 8.79 mm | $96.20 mm |
Frazier Life Sciences Management | 8.79 mm | $81.70 bn |
Vanguard | 6.96 mm | $64.75 bn |
Polar Capital | 6.88 mm | $64.02 bn |
STT State Street | 5.64 mm | $52.47 bn |
BEN Franklin Resources | 4.25 mm | $41.40 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | Howard G. Welgus | Common Stock | Sell | Dispose S | No | Yes | 14.6714 | 10,000 | 146.71 k | 151,944 |
31 Dec 24 | Patrick Burnett | Common Stock | Sell | Dispose S | No | No | 14 | 1,691 | 23.67 k | 126,978 |
20 Dec 24 | Todd Franklin Watanabe | Common Stock | Sell | Dispose S | No | Yes | 15.1711 | 15,000 | 227.57 k | 823,430 |
2 Dec 24 | Howard G. Welgus | Common Stock | Sell | Dispose S | No | Yes | 12.5133 | 10,000 | 125.13 k | 161,944 |
30 Nov 24 | Larry Todd Edwards | Common Stock | Buy | Acquire P | No | No | 7.106 | 1,093 | 7.77 k | 137,728 |